image
Adverum Biotechnologies, Inc. ADVM
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.86
-5.38 %
$ 143 M
Market Cap
-1.2
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% 24.18% 21.22%
Annual Report FY 10-K 2022-12-31 0.00% -6.18% -7.54%
Annual Report FY 10-K 2021-12-31 0.00% -23.86% -23.88%
Annual Report FY 10-K 2020-12-31 0.00% -82.22% -72.08%
Annual Report FY 10-K 2019-12-31 -84.49% 11.21% 12.21%
Annual Report FY 10-K 2018-12-31 -12.82% -29.35% -32.68%
Annual Report FY 10-K 2017-12-31 27.08% 50.64% 48.95%
Annual Report FY 10-K 2016-12-31 -37.26% -139.70% -141.06%
Annual Report FY 10-K 2015-12-31 305.42% -86.79% -95.98%
Annual Report FY 10-K 2014-12-31 19.17% -381.50% -606.49%
Annual Report FY 10-K 2013-12-31 1500.00% -191.33% -90.20%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% 17.49% 11.03%
Quarterly Report Q2 8-K 2024-06-30 0.00% 41.36% 12.05%
Quarterly Report Q1 8-K 2024-03-31 0.00% 14.69% 6.94%
Quarterly Report Q4 8-K 2023-12-31 0.00% 27.56% 23.52%
Quarterly Report Q3 8-K 2023-09-30 0.00% 18.06% 15.86%
Quarterly Report Q2 8-K 2023-06-30 0.00% 28.00% 24.89%
Quarterly Report Q1 8-K 2023-03-31 0.00% 23.35% 20.70%
Quarterly Report Q4 8-K 2022-12-31 100.00% 4.86% 1.39%
Quarterly Report Q3 8-K 2022-09-30 0.00% -4.61% -6.53%
Quarterly Report Q2 8-K 2022-06-30 0.00% 1.29% 1.15%
Quarterly Report Q1 8-K 2022-03-31 0.00% -33.31% -33.13%
Quarterly Report Q4 8-K 2021-12-31 0.00% 8.56% 5.39%
Quarterly Report Q3 8-K 2021-09-30 0.00% -38.15% -37.56%
Quarterly Report Q2 8-K 2021-06-30 0.00% -51.83% -49.58%
Quarterly Report Q1 8-K 2021-03-31 0.00% -24.14% -20.39%
Quarterly Report Q4 8-K 2020-12-31 100.00% -98.85% -85.11%
Quarterly Report Q3 8-K 2020-09-30 0.00% -72.29% -63.93%
Quarterly Report Q2 8-K 2020-06-30 0.00% -95.27% -84.91%
Quarterly Report Q1 8-K 2020-03-31 0.00% -58.09% -51.47%
Quarterly Report Q4 8-K 2019-12-31 -357.14% -20.86% -17.27%
Quarterly Report Q3 8-K 2019-09-30 -69.99% 23.09% 27.22%
Quarterly Report Q2 8-K 2019-06-30 0.00% 20.50% 19.10%
Quarterly Report Q1 8-K 2019-03-31 0.00% 15.76% 12.48%
Quarterly Report Q4 8-K 2018-12-31 -84.82% -5.88% -7.46%
Quarterly Report Q3 8-K 2018-09-30 79.91% -51.55% -61.09%
Quarterly Report Q2 8-K 2018-06-30 6.48% -64.57% -64.58%
Quarterly Report Q1 8-K 2018-03-31 -53.25% -6.84% -8.19%
Quarterly Report Q4 8-K 2017-12-31 -5.53% 33.96% 33.32%
Quarterly Report Q3 8-K 2017-09-30 17.22% 3.30% -0.44%
Quarterly Report Q2 8-K 2017-06-30 50.81% 81.46% 80.46%
Quarterly Report Q1 8-K 2017-03-31 74.34% -4.59% -6.96%
Quarterly Report Q4 8-K 2016-12-31 -49.17% -58.89% -64.94%
Quarterly Report Q3 8-K 2016-09-30 -58.55% -1.54% -2.15%
Quarterly Report Q2 8-K 2016-06-30 51.23% -531.37% -526.21%
Quarterly Report Q1 8-K 2016-03-31 30.54% -61.87% -62.20%
Quarterly Report Q4 8-K 2015-12-31 372.91% -35.64% -36.30%
Quarterly Report Q3 8-K 2015-09-30 367.16% -70.59% -78.85%
Quarterly Report Q2 8-K 2015-06-30 50.37% -91.72% -121.92%
Quarterly Report Q1 8-K 2015-03-31 576.67% -471.80% -495.33%
Quarterly Report Q4 8-K 2014-12-31 0.00% -181.37% -439.29%
Quarterly Report Q3 8-K 2014-09-30 580.00% -915.50% -920.57%
Quarterly Report Q2 8-K 2014-06-30 -10.00% -606.52% -531.63%
Quarterly Report Q1 8-K 2014-03-31 -90.00% -3293.88% -3723.81%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%